Immunic (IMUX) EPS (Weighted Average and Diluted) (2019 - 2026)
Immunic's (IMUX) quarterly EPS (Weighted Average and Diluted) came in at -$1.08 in Q1 2026, up 56.97% year-on-year from -$0.69 in Q1 2025, and down 1442.86% quarter-over-quarter from -$0.07 in Q4 2025.
Immunic (IMUX) EPS (Weighted Average and Diluted) (2019 - 2026) Analysis & Trends
Immunic has disclosed EPS (Weighted Average and Diluted) across 8 years of filings, most recently posting -$1.08 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$1.08, up 56.97% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.48 (up 53.89% YoY), and the FY2025 annual result was -$0.62, up 38.0% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$1.08 for Q1 2026 at Immunic, down from -$0.07 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.07 in Q4 2025 to a low of -$2.51 in Q1 2025.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.51 (2023), against an average of -$0.64.
- Peak annual rise in EPS (Weighted Average and Diluted) reached 72.0% in 2025, while the deepest fall reached 736.67% in 2025.
- Immunic's EPS (Weighted Average and Diluted) stood at -$1.62 in 2022, then surged by 70.37% to -$0.48 in 2023, then surged by 47.92% to -$0.25 in 2024, then surged by 72.0% to -$0.07 in 2025, then sank by 1442.86% to -$1.08 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$1.08 (Q1 2026), -$0.07 (Q4 2025), and -$0.13 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.61 |
| 10 | Immunic | 384.84 Mn | 198.21 Mn | - | -1.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.08 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -0.20 |
| Mar 31, 2025 | -2.51 |
| Dec 31, 2024 | -0.25 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | -0.21 |
| Mar 31, 2024 | -0.30 |
| Dec 31, 2023 | -0.48 |
| Sep 30, 2023 | -0.51 |
| Jun 30, 2023 | -0.54 |
| Mar 31, 2023 | -0.58 |
| Dec 31, 2022 | -1.62 |
| Sep 30, 2022 | -0.69 |
| Jun 30, 2022 | -0.72 |
| Mar 31, 2022 | -0.74 |
| Dec 31, 2021 | -0.81 |
| Sep 30, 2021 | -0.76 |
| Jun 30, 2021 | -0.82 |